Fratzl‐Zelman, N., Hartmann, M. A., Gamsjaeger, S., Rokidi, S., Paschalis, E. P., Blouin, S., & Zwerina, J. (2022). Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial. Journal of bone and mineral research, 37(9), 1665-1678. https://doi.org/10.1002/jbmr.4641
Chicago Style (17th ed.) CitationFratzl‐Zelman, Nadja, Markus A. Hartmann, Sonja Gamsjaeger, Stamatia Rokidi, Eleftherios P. Paschalis, Stéphane Blouin, and Jochen Zwerina. "Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial." Journal of Bone and Mineral Research 37, no. 9 (2022): 1665-1678. https://doi.org/10.1002/jbmr.4641.
MLA (9th ed.) CitationFratzl‐Zelman, Nadja, et al. "Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X‐Linked Hypophosphatemia: Results From the Phase 3, Single‐Arm International Trial." Journal of Bone and Mineral Research, vol. 37, no. 9, 2022, pp. 1665-1678, https://doi.org/10.1002/jbmr.4641.